Will venetoclax (venetoclax) be reimbursed by medical insurance in 2024? What is the price?

Venetoclax, also known as venetoclax, is a new type of oral targeted drug that is a small molecule inhibitor ofBCL-2. It plays a key role in the treatment of lymphomas and leukemias that overexpress the BCL-2 gene by inhibiting B-cell lymphoma 2 (BCL-2), a protein that promotes cell survival, and restoring the normal apoptosis process of abnormal B cells. Especially for chronic lymphocytic leukemia, Crombei's lymphoma, etc., venetoclax has shown significant therapeutic effects.

In addition, venetoclax is also used in combination with azacitidine for the treatment of newly diagnosed adult patients with acute myeloid leukemia who are not suitable for intensive induction chemotherapy due to comorbidities or who are 75 years or older. Its medication method has a specific dose ramping period and is combined with azacitidine in each course of treatment to achieve the best therapeutic effect.

However, the use of venetoclax may also be associated with some side effects, such as gastrointestinal reactions, allergic reactions, and neutropenia due to bone marrow suppression. Therefore, the patient's response needs to be closely monitored during medication and the treatment plan adjusted accordingly.

Venetoclax, newly launched in China in 2020, is already covered by medical insurance and has specific effects on adult patients with acute myeloid leukemia. in the country, 14 tablets of 100mg Venecela only cost about 2,000 yuan after medical insurance reimbursement. In addition, overseas, both original and generic drugs are available, and the price of 112 pills of the original version is approximately 16,500 yuan. However, the price of generic drugs in Laos and Bangladesh is more affordable, with the price of 112 pills ranging from 2,500 to 6,000 yuan, and the user reviews are quite high.

Overall, as an innovative anti-tumor drug, venetoclax’s unique mechanism of action and significant therapeutic effects provide new treatment options for patients with leukemia and lymphoma. When using, patients should follow their doctor's advice to ensure safe and effective use of this medication.